Study of Pazopanib in the Treatment of Surgically Unresectable or Metastatic Liposarcoma

NCT01506596 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

42

Enrollment

OTHER

Sponsor class

Conditions

Liposarcoma
Surgically Unresectable Liposarcoma
Metastatic Liposarcoma

Interventions

DRUG: pazopanib

Sponsor

Vector Oncology

Collaborators

[object Object]